Campath and renal failure Patient Reports February 11, 2012

Campath Side Effects Report #5906991-1
Campath side effect was reported by a Health Professional from UNITED STATES on Sept 19, 2008. Male patient, 51 years of age, was diagnosed with renal transplant, antiviral prophylaxis, antifungal prophylaxis and was treated with Campath. After drug was administered, patient experienced the following side effects: coccidioidomycosis, renal failure, respiratory failure, sepsis , thrombocytopenia. Campath dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, DIPHENHYDRAMINE, METHYLPREDNISOLONE, VALCYTE, MYCELEX, TRIMETHOPRIM, PROGRAF, CELLCEPT. Patient was hospitalized. Patient died.

Campath Side Effects Report #5899755-9
Campath side effect was reported by a Physician from UNITED STATES on Sept 16, 2008. Male patient, 15 years of age, weighting 158.7 lb, was diagnosed with renal transplant and was treated with Campath. After drug was administered, patient experienced the following side effects: arteriovenous fistula occlusion, catheter placement, diarrhoea, focal segmental glomerulosclerosis, gastroenteritis , hypotension, renal failure, thrombosis. Campath dosage: AS USED: 18.5 MG. During the same period patient was treated with ACETAMINOPHEN, AMLODIPINE, CEFTRIAXONE, CLOTRIMAZOLE, DAPSONE. Patient was hospitalized. Patient recovered.

Campath Side Effects Report #5956646-2
Campath side effect was reported by a Physician from UNITED STATES on Nov 10, 2008. Male patient, 15 years of age, weighting 158.7 lb, was diagnosed with renal transplant and was treated with Campath. After drug was administered, patient experienced the following side effects: arteriovenous fistula occlusion, arteriovenous fistula thrombosis, diarrhoea, focal segmental glomerulosclerosis, gastroenteritis , hypotension, renal failure. Campath dosage: AS USED: 18.5 MG. During the same period patient was treated with ACETAMINOPHEN, AMLODIPINE, CEFTRIAXONE, CLOTRIMAZOLE. Patient was hospitalized. Patient recovered.

Campath Side Effects Report #6114678-8
Campath side effect was reported by a Physician from UNITED STATES on Mar 05, 2009. Male patient, 15 years of age, weighting 158.7 lb, was diagnosed with renal transplant and was treated with Campath. After drug was administered, patient experienced the following side effects: arteriovenous fistula occlusion, arteriovenous fistula thrombosis, diarrhoea, focal segmental glomerulosclerosis, gastroenteritis , graft loss, hypotension, renal failure. Campath dosage: AS USED: 18.5 MG. During the same period patient was treated with ACETAMINOPHEN, AMLODIPINE, CEFTRIAXONE, CLOTRIMAZOLE. Patient was hospitalized. Patient recovered.


Campath Side Effects Report #5294378-7
Campath side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 09, 2007. Male patient was diagnosed with mycosis fungoides and was treated with Campath. After drug was administered, patient experienced the following side effects: cytomegalovirus viraemia, enterococcal infection, renal failure, respiratory failure, tumour lysis syndrome. Campath dosage: 30MG. Patient was hospitalized. Patient recovered.

Campath Side Effects Report #5951261-9
Campath side effect was reported by a Physician from UNITED KINGDOM on Nov 04, 2008. Female patient, 39 years of age, was diagnosed with multiple sclerosis  and was treated with Campath. After drug was administered, patient experienced the following side effects: burkitt's lymphoma, disseminated intravascular coagulation, meningitis , neutropenic sepsis, renal failure. Campath dosage: UNIT DOSE: 24 MG. Patient was hospitalized. Patient died on 11/04/2008.

Campath Side Effects Report #5955011-1
Campath side effect was reported by a Physician from UNITED KINGDOM on Nov 04, 2008. Female patient, 39 years of age, was diagnosed with multiple sclerosis  and was treated with Campath. After drug was administered, patient experienced the following side effects: burkitt's lymphoma, disseminated intravascular coagulation, meningitis , neutropenic sepsis, renal failure. Campath dosage: UNIT DOSE: 24 MG. Patient was hospitalized. Patient died on 11/04/2008.

Campath Side Effects Report #5811476-7
Campath side effect was reported by a Health Professional from UNITED STATES on July 10, 2008. Male patient, 77 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath. After drug was administered, patient experienced the following side effects: bacteraemia, hyponatraemia, renal failure, urinary tract infection . Campath dosage: UNIT DOSE: 30 MG. During the same period patient was treated with FLUDARA. Patient was hospitalized. Patient recovered.

Campath Side Effects Report #5080232-2
Campath side effect was reported by a Physician from UNITED STATES on Aug 03, 2006. Male patient, 76 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath. After drug was administered, patient experienced the following side effects: anaemia, bacteraemia, condition aggravated, confusional state, hyponatraemia, lethargy, renal failure, urinary retention, urinary tract infection . Campath dosage: unknown. During the same period patient was treated with FLUDARA, DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN, EPOETIN ALFA, RED BLOOD CELLS. Patient was hospitalized. Patient recovered.


Campath Side Effects Report #5412687-5
Campath side effect was reported by a Health Professional from UNITED STATES on Aug 07, 2007. Male patient, 76 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath. After drug was administered, patient experienced the following side effects: bacteraemia, hyponatraemia, renal failure, urinary tract infection . Campath dosage: 30 MG, D1-5 EVERY 28 DAYS. During the same period patient was treated with FLUDARA. Patient was hospitalized. Patient recovered.

Campath Side Effects Report #6068227-3
Campath side effect was reported by a Physician from GERMANY on Jan 23, 2009. Male patient, 60 years of age, weighting 134.5 lb, was diagnosed with chronic lymphocytic leukaemia, renal failure, prophylaxis and was treated with Campath. After drug was administered, patient experienced the following side effects: renal failure, tumour lysis syndrome. Campath dosage: UNIT DOSE: 3 MG. During the same period patient was treated with FLUDARABINE PHOSPHAT, FLUDARABINE PHOSPHAT, LORZAAR PLUS, VALACYCLOVIR, COTRIM DS. Patient was hospitalized. Patient recovered.

Campath Side Effects Report #5866933-4
Campath side effect was reported by a Physician from UNITED STATES on Aug 26, 2008. Male patient, 58 years of age, weighting 196.2 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath. After drug was administered, patient experienced the following side effects: adenovirus infection, bronchopneumonia, chronic lymphocytic leukaemia, hypoxic encephalopathy, obstructive uropathy, renal failure. Campath dosage: unknown. During the same period patient was treated with FLUDARA, ADRIAMYCIN PFS, RITUXAN, ADRIAMYCIN PFS, VINCRISTINE, NEULASTA. Patient was hospitalized. Patient died on 11/27/2006.

Campath Side Effects Report #5652978-6
Campath side effect was reported by a Physician from JAPAN on Feb 25, 2008. Male patient, 34 years of age, was diagnosed with bone marrow conditioning regimen and was treated with Campath. After drug was administered, patient experienced the following side effects: blood stem cell transplant failure, engraftment syndrome, renal failure. Campath dosage: unknown. During the same period patient was treated with FLUDARA. Patient was hospitalized. Patient died on 02/11/2008.

Campath Side Effects Report #5269176-0
Campath side effect was reported by a Physician from UNITED STATES on Mar 13, 2007. Male patient, 58 years of age, weighting 196.0 lb, was treated with Campath. After drug was administered, patient experienced the following side effects: adenovirus infection, bronchopneumonia, chronic lymphocytic leukaemia transformation, hypoxic encephalopathy, renal failure. Campath dosage: unknown. During the same period patient was treated with FLUDARA, ADRIAMYCIN PFS, RITUXAN, ADRIAMYCIN PFS, VINCRISTINE, NEULASTA. Patient was hospitalized. Patient died on 11/27/2006.


Campath Side Effects Report #5274162-0
Campath side effect was reported by a Physician from UNITED STATES on Mar 19, 2007. Male patient, 58 years of age, weighting 196.0 lb, was treated with Campath. After drug was administered, patient experienced the following side effects: adenovirus infection, bronchopneumonia, hypoxic encephalopathy, obstructive uropathy, renal failure. Campath dosage: unknown. During the same period patient was treated with FLUDARA, ADRIAMYCIN PFS, RITUXAN, ADRIAMYCIN PFS, VINCRISTINE, NEULASTA. Patient was hospitalized. Patient died on 11/27/2006.

Campath Side Effects Report #5105185-X
Campath side effect was reported by a Physician from UNITED STATES on Sept 05, 2006. Female patient, 38 years of age, was diagnosed with prophylaxis and was treated with Campath. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, lung infection, malignant neoplasm progression, myopathy steroid, pleural effusion, pulmonary haemorrhage, renal failure, respiratory failure. Campath dosage: 50 MG, D-7 TO D-3, INTRAVENOUS. During the same period patient was treated with FLUDARA, CYCLOPHOSPHAMIDE, MESNA, BACTRIM, MS CONTIN, VICODIN, MS CONTIN, LEVOTHYROXINE. Patient was hospitalized. Patient died on 08/10/2006.

Campath Side Effects Report #4577995-9
Campath side effect was reported by a Health Professional from on Jan 26, 2005. Female patient, 37 years of age, weighting 275.6 lb, was treated with Campath. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anuria, disseminated intravascular coagulation, haemodialysis, poor venous access, pulmonary embolism , pyrexia, renal failure. Campath dosage: 10 MG 2 INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, HYDROXYURIEA, ALLOPURINOL, ITRACONAZOLE. Patient was hospitalized. Patient recovered.

Campath Side Effects Report #5346414-7
Campath side effect was reported by a Physician from GERMANY on May 21, 2007. Male patient, weighting 176.4 lb, was treated with Campath. After drug was administered, patient experienced the following side effects: renal failure, tumour lysis syndrome. Campath dosage: 30 MG/D, UNK. During the same period patient was treated with ACETAMINOPHEN, TAVEGIL. Patient was hospitalized. Patient died on 10/29/2004.

Campath Side Effects Report #5360827-9
Campath side effect was reported by a Physician from GERMANY on June 18, 2007. Male patient, weighting 176.4 lb, was treated with Campath. After drug was administered, patient experienced the following side effects: renal failure, tumour lysis syndrome. Campath dosage: 30 MG/D, UNK. During the same period patient was treated with ACETAMINOPHEN, TAVEGIL. Patient was hospitalized. Patient died on 10/29/2004.


Campath Side Effects Report #5373457-X
Campath side effect was reported by a Physician from GERMANY on June 18, 2007. Male patient, weighting 176.4 lb, was treated with Campath. After drug was administered, patient experienced the following side effects: renal failure, tumour lysis syndrome. Campath dosage: 30 MG/D, UNK. During the same period patient was treated with ACETAMINOPHEN, TAVEGIL. Patient was hospitalized. Patient died on 10/29/2004.

Campath Side Effects Report #4663891-5
Campath side effect was reported by a Health Professional from on May 03, 2005. Male patient was treated with Campath. After drug was administered, patient experienced the following side effects: anaemia, renal failure, respiratory disorder, white blood cell count increased. Campath dosage: unknown. Patient died on 04/01/2005.

Campath Side Effects Report #4960092-8
Campath side effect was reported by a Health Professional from UNITED STATES on Mar 22, 2006. Male patient was treated with Campath. After drug was administered, patient experienced the following side effects: anaemia, renal failure, respiratory disorder, white blood cell count increased. Campath dosage: 30 MG, 3X/WEEK; SEE IMAGE. Patient died on 04/01/2005.